Robert Negrin and Antony Letai
Mar 31, 2026, 16:03
Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
Robert Negrin, President of ASH, Professor at Stanford University, shared a post on LinkedIn:
“On behalf of the ASH leadership, thank you to Dr. Letai and NCI colleagues for meeting with us and sharing your vision and priorities for the Institute.
We also appreciated the opportunity to share details about ASH’s expanded efforts to support hematology research, promote the next generation of the hematology research workforce, and highlight other ASH programs.
We look forward to collaborating during this exciting time in science, while addressing some of the ongoing challenges we are seeing in research and clinical practice.
We look forward to seeing Dr. Letai at the annual meeting in New Orleans!”
Stay updated with Hemostasis Today.
-
Mar 31, 2026, 16:02Jim Hoffman: Does Multiomics Suggest LC PASC Patients Require Multiple Drugs to Correct Biochemical Dysregulation?
-
Mar 31, 2026, 15:59Seema Dawood: How Blister Cells Reveal Oxidative Damage in G6PD Deficiency
-
Mar 31, 2026, 15:57Ney Carter Borges: HOST-EXAM Shows Clopidogrel Beats Aspirin in Long-Term Monotherapy
-
Mar 31, 2026, 15:57Join the Webinar on Immunoglobulin Access and Stewardship in the UK and Australia – ISBT
-
Mar 31, 2026, 15:55Hind El Azzazi: Successful Defense of My Medical Doctorate on Antiphospholipid Syndrome in Men
-
Mar 31, 2026, 15:54Rucha Patil: Honored to Speak at AIIMS Nagpur ToT Workshop on Advancing Hemophilia A Care
-
Mar 31, 2026, 15:43Deepak Sudheendra: When the Clot Is Gone, but Symptoms Stay
-
Mar 31, 2026, 15:25Chokri Ben Lamine: Pathophysiology, Diagnosis and Management of Hereditary Spherocytosis
-
Mar 31, 2026, 15:15Kristopher Jonas: Why Donors Show Up and Why It All Matters